Related Experiment Video
Updated: Aug 12, 2026

Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier
Published on: April 5, 2017
Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with
J Kraus1, B Engelhardt, N Chatzimanolis
1Department of Neurology, Justus-Liebig University Giessen, Research Group for Multiple Sclerosis and Neuroimmunology, Am Steg 14, 35385, Giessen, Germany. joerg.r.kraus@neuro.med.uni-giessen.de
Background:
The expression of soluble cell adhesion molecules (AM) in cerebrospinal fluid (CSF) and blood and their significance as measures of disease activity has been extensively studied in patients with multiple sclerosis (MS). In previous studies, we found that cell surface bound AM on mononuclear cells (MNC) in CSF and blood might be useful markers of clinical disease activity in MS patients.
Objective:
To analyze the correlation of cell surface bound and soluble AM in CSF and blood with magnetic resonance imaging (MRI) markers of subclinical disease severity and activity in patients with MS.
Methods:
Expression levels of cell surface bound AM on peripheral blood and CSF MNC were determined by flow cytometry analysis in 77 (CSF: 33) MS patients. Concentration levels of the soluble forms of AM were measured by enzyme-linked immunosorbent assay (ELISA). In corresponding cerebral gadolinium (Gd)-enhanced MRI scans, we determined both measures of subclinical disease severity and subclinical disease activity.
Results:
The expression levels of cell surface bound AM in peripheral blood correlated inversely with parameters for subclinical disease severity and activity on cerebral MRI scans as well as with the disease duration. Furthermore, we found significant correlations between serum levels of soluble AM and patient age but not with disease duration.
Conclusions:
Our results suggest that subclinical disease progression may be associated with a decrease of the expression of cell surface bound AM on peripheral blood MNC. This might be a result of activated MNC migration into the CNS.
Insights
Decreased cell surface bound adhesion molecules (AM) in the blood of multiple sclerosis (MS) patients may indicate subclinical disease progression and central nervous system (CNS) involvement.
Area of Science:
- Neuroimmunology
- Biomarker Discovery
Background:
- Soluble cell adhesion molecules (AM) in cerebrospinal fluid (CSF) and blood are studied for multiple sclerosis (MS) disease activity.
- Previous research indicated cell surface bound AM on mononuclear cells (MNC) in CSF and blood may reflect clinical MS activity.
Purpose of the Study:
- To correlate cell surface bound and soluble AM in CSF and blood with MRI markers of subclinical MS disease severity and activity.
Main Methods:
- Flow cytometry analyzed cell surface bound AM on MNC from 77 MS patients (33 CSF).
- Enzyme-linked immunosorbent assay (ELISA) measured soluble AM concentrations.
- Gadolinium-enhanced MRI assessed subclinical disease severity and activity.
Main Results:
- Cell surface bound AM in peripheral blood inversely correlated with subclinical disease severity and activity on MRI, and disease duration.
- Soluble AM serum levels correlated with patient age, but not disease duration.
Conclusions:
- Decreased expression of cell surface bound AM on peripheral blood MNC may be linked to subclinical MS progression.
- This decrease might reflect activated MNC migration into the central nervous system (CNS).
More Related Videos
Related Concept Videos
Cell Adhesion Molecules - Types and Functions
CAM Families
The Integrin family of proteins is primarily involved in a...
Selectins
Immunoglobulin-like Cell Adhesion Molecules
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Multiple Sclerosis l: Introduction

